I am not protecting the FDA. I only hope to protect our
I am not protecting the FDA. I only hope to protect our investment is all. My motives only are to the success of Cytodyn. My thoughts were that we may of caused the response that the FDA did with their letter. I can’t say the investors did cause it but it can be construed that way. It’s my interpretation of why the letter was written to slow the attack of the investors. It makes sense but can’t confirm it.
When you have what could be well over a thousand and maybe 10,000 investors writing the FDA and or politicians you don’t know what your going to get. Everybody will write something different and many will not be tactful in the words they choose. Could be downright derogatory with cussing and name calling. Those letters will represent us all as investors. May do more harm than good. Not the wisest response in my opinion.
My interpretation of the events are in the best interest of our investment and nothing more. I have watched the rudeness on the chat boards and can only imagine how nasty some of the letters have been. I personally believe that would be wrong to be nasty to a group of regulators we need to get approvals from in the future. It just doesn’t make sense and using common sense knowing we should not is all I have tried to make known. At this point all I can say is if anyone still has the need to complain directly to the FDA in the future. To be respectful and smart on how you word your letter to not further the alienation of the FDA any further. That is my biggest concern for the future of our company. It would of been better to have one person write a letter and for everyone to sign that letter in support than to have 10,000 what could be nasty letters.
My perception is for the good of the company. I am well aware of the people on not just this board writing some terrible stuff and rallying other to write the FDA and let them have it... so to speak. Explain to me how even 1,000 terribly written letters can help us? Tell me how that would be in the best interest of the company?
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...
Continue Reading
A blockchain partnership can sound like confetti until the plumbing matters. This one at least points at a real commercial choke point: Asian-originated tokenized assets need deeper pools of global onchain capital, while global networks need credible asset supply and institutional access. HashKey Group's HSK Chain and Coinbase-built Base say they intend to tackle both...
Continue Reading
Money laundering rarely travels in a straight line, and that is precisely the sore spot VisionX AI is trying to jab. The Singapore-based RegTech company has introduced AEGIS, a proprietary Large Graph Model built around financial-crime networks, alongside TraceX, a blockchain investigation platform meant to turn that network view into usable leads. It is a sensible...
Continue Reading
Debt cleanup arrives with a hard ceiling Eight far-dated bond issues just got a very specific invitation from Charter Communications: hand them over for cash, but do not expect the company to write a blank check. Charter set final pricing on November 17 for tender offers covering up to $1.5 billion in aggregate consideration, excluding accrued interest and deal expenses....
Continue Reading
Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...
Continue Reading
Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...
Continue Reading
A suite change inside downtown Minneapolis is usually wallpaper, but this one carries a little more weight. Trinity Logistics has moved its Minneapolis team from Suite 1850 to Suite 1700 at 100 S. 5th Street, saying the larger space is needed for continued growth and future opportunity. Nobody should confuse an office relocation with a freight-cycle victory lap. Still,...
Continue Reading
A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...
Continue Reading
A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...
Continue Reading
Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...
Continue Reading
Top 5 Most Recently Viewed Articles
Shareholder Meetings on the Horizon As we move into a new reporting season, the excitement surrounding the upcoming shareholder meetings is palpable. The recent financial results indicate a strong finish to the last quarter, with many companies showcasing impressive growth despite emerging macro challenges. The period after Q4 reporting sees a shift in focus toward the...
Continue Reading
Worldline Welcomes Pierre-Antoine Vacheron as CEO Worldline, a leader in digital payments, has recently announced the appointment of Pierre-Antoine Vacheron as its new Chief Executive Officer. This strategic move, effective from March 1, signals a fresh start for the company as it continues to evolve within the rapidly changing payments industry. A Seasoned Professional...
Continue Reading
Autolus Therapeutics to Release Financial Results Soon Autolus Therapeutics plc (NASDAQ: AUTL), a pioneering biopharmaceutical company, is gearing up to share its financial results for the second quarter of 2025. This announcement is set for shortly before the opening of U.S. markets. As a company focusing on next-generation programmed T cell therapies, the anticipation...
Continue Reading
New Brand Strategy in Atlanta's Dental Scene In an era where large dental chains seem to gobble up neighborhood practices like some corporate Pac-Man, Dr. Patrice Robbins takes a refreshing turn. Her brainchild, Brightworks Dentistry, is roping in all its Atlanta bases under one banner to keep that local warmth alive. By grouping Dunwoody, Buckhead, and Downtown Atlanta...
Continue Reading
Recent Insights from Analysts on AutoNation Wall Street analysts have recently published their latest evaluations of several well-known companies, presenting a blend of ratings and insights. In this article, we’ll explore the most recent coverage initiated by leading analysts, focusing specifically on AutoNation, Inc. and other notable companies. Understanding the...
Continue Reading